131_I治疗甲状腺功能亢进症的疗效及其影响因素.pdfVIP

39 6 845 () ol. 39 No. 6 P. 845 2010 12 A cta Med Univ SciT echnol Huazhong Dec. 2010 131I 覃春霞, 曹 卫, 兰晓莉, 高再荣, 曹国祥, 张永学 , , 430022 131 : I ( ) ,( ) 131 2003 ~ 2007 I 162 : 131 131 131 , I , I , 24 h I , 131 I 136 72.2%, 100.0%;56. 8%, 97. 5%; 1 FT FT ; 3 4 , 24 h , 131I ; , 24 h 131I , , 131 , I : ; 131I ; : R817. 8 DOI:10. 3870/ j. issn.2010.06. 027 Analysis of the Curative Effect of 131 I Therapy for Hyperthyroidism and the Influencing Factors Qin Chunxia,Cao Wei,Lan Xiaoli et al Dep artment of N uclear Medicine, Union H osp ital, Tongj i Medical College, H uazhong University of Science and Technology , H ubei rov ince K ey L aboratory of Molecular I maging , Wuhan 430022, China A stract O jective To evaluate the therapeutic effect of 131I therapy in patients with hyperthyroidism, and analyze the factors which could influence the curative effect and hypothyroidism occurrence.Methods We retrospectively studied 162 pa tients with definite diagnosis of hyperthyroidism receiving 131I treatment from 2003 to 2007. All patients had complete followup data, and had no contraindication for 131I therapy. The dose of 131I was calculated and adjusted according to the weight of thy roid, the iodide uptake rate and patient condition.T he regular